TY - JOUR T1 - Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy JF - European Respiratory Journal JO - Eur Respir J SP - 390 LP - 417 DO - 10.1183/09031936.00060806 VL - 29 IS - 2 AU - P. Tønnesen AU - L. Carrozzi AU - K. O. Fagerström AU - C. Gratziou AU - C. Jimenez-Ruiz AU - S. Nardini AU - G. Viegi AU - C. Lazzaro AU - I. A. Campell AU - E. Dagli AU - R. West Y1 - 2007/02/01 UR - http://erj.ersjournals.com/content/29/2/390.abstract N2 - Smoking cessation is the one of the most important ways to improve the prognosis of patients with respiratory disease. The Task Force on guidelines for smoking cessation in patients with respiratory diseases was convened to provide evidence-based recommendations on smoking cessation interventions in respiratory patients. Based on the currently available evidence and the consensus of an expert panel, the following key recommendations were made. 1) Patients with respiratory disease have a greater and more urgent need to stop smoking than the average smoker, so respiratory physicians must take a proactive and continuing role with all smokers in motivating them to stop and in providing treatment to aid smoking cessation. 2) Smoking cessation treatment should be integrated into the management of the patient's respiratory condition. 3) Therapies should include pharmacological treatment (i.e. nicotine replacement therapy, bupropion or varenicline) combined with behavioural support. 4) Respiratory physicians should receive training to ensure that they have the knowledge, attitudes and skills necessary to deliver these interventions or to refer to an appropriate specialist. 5) Although the cost of implementing these recommendations will partly be offset by a reduction in attendance for exacerbations, etc., a budget should be established to enable implementation. Research is needed to establish optimum treatment strategies specifically for respiratory patients. ER -